<DOC>
	<DOCNO>NCT02514486</DOCNO>
	<brief_summary>This study describe patient-reported symptom burden concern , quality life ( QOL ) , health behavior breast cancer ( BC ) survivor complete initial treatment ( e.g. , surgery , chemotherapy , and/or radiotherapy ) , assess feasibility use web-based platform collect patient-reported outcome ( PRO ) data , evaluate provider satisfaction follow delivery electronic health record ( HER ) /EPIC summary PROs . Secondary aim estimate difference referral available service provider expose PRO summary historical control . BC survivor complete initial treatment present within first year follow treatment end treatment ( EOT ) /survivorship focus visit focus study .</brief_summary>
	<brief_title>Assessment Cancer Concerns End Treatment ( ACE )</brief_title>
	<detailed_description />
	<criteria>1 . Diagnosed invasive , nonmetastatic BC ( Stage I , II , III ) without hematogenous distant metastasis 2 . Have complete initial treatment ( chemotherapy , radiotherapy , and/or surgery ) . May still receive hormonal target therapy ( e.g. , tamoxifen , aromatase inhibitor ) . 3 . Within 1 year complete primary treatment 4 . Scheduled EOT visit 5 . Age 18 year old 6 . Can understand write English 7 . Have internet access work email address 1 . Diagnosed noninvasive ( Stage 0/DCIS ) metastatic ( Stage IV ) cancer hematogenous distant metastatic disease 2 . No work email address</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>